The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 4,747 | 275,333 | SH | SOLE | 275,333 | 0 | 0 | ||
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 23 | 10,659 | SH | SOLE | 10,659 | 0 | 0 | ||
AMRYT PHARMA PLC | SPONSORED ADS | 03217L106 | 1,268 | 153,267 | SH | SOLE | 153,267 | 0 | 0 | ||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 386 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 5,354 | 105,368 | SH | SOLE | 105,368 | 0 | 0 | ||
APOLLO ENDOSURGERY INC | COM | 03767D108 | 6,077 | 1,004,399 | SH | SOLE | 1,004,399 | 0 | 0 | ||
APTINYX INC | COM | 03836N103 | 458 | 201,600 | SH | Put | SOLE | 201,600 | 0 | 0 | |
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 1,428 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
ASLAN PHARMACEUTICALS LTD | ADS | 04522R101 | 1,592 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 26,964 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 177 | 1,235,784 | SH | SOLE | 1,235,784 | 0 | 0 | ||
BENITEC BIOPHARMA INC | COM | 08205P100 | 57 | 492,880 | SH | SOLE | 492,880 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 197 | 102,425 | SH | SOLE | 102,425 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 230 | 10,248 | SH | SOLE | 10,248 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 4,359 | 102,497 | SH | SOLE | 102,497 | 0 | 0 | ||
CALITHERA BIOSCIENCES INC | COM | 13089P101 | 74 | 221,809 | SH | SOLE | 221,809 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 256 | 45,538 | SH | SOLE | 45,538 | 0 | 0 | ||
CERUS CORP | COM | 157085101 | 7,677 | 1,398,400 | SH | SOLE | 1,398,400 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 1,670 | 81,000 | SH | SOLE | 81,000 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 4,297 | 573,699 | SH | SOLE | 573,699 | 0 | 0 | ||
COMPUGEN LTD | ORD | M25722105 | 865 | 268,596 | SH | SOLE | 268,596 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 2,502 | 114,004 | SH | SOLE | 114,004 | 0 | 0 | ||
CTI BIOPHARMA CORP | COM | 12648L601 | 10,508 | 2,250,000 | SH | SOLE | 2,250,000 | 0 | 0 | ||
CYCLACEL PHARMACEUTICALS INC | COM | 23254L603 | 1,411 | 462,659 | SH | SOLE | 462,659 | 0 | 0 | ||
ELIEM THERAPEUTICS INC | COM | 28658R106 | 741 | 88,279 | SH | SOLE | 88,279 | 0 | 0 | ||
ELOXX PHARMACEUTICALS INC | COM | 29014R103 | 1,092 | 1,950,949 | SH | SOLE | 1,950,949 | 0 | 0 | ||
EVOGENE LTD | SHS | M4119S104 | 384 | 295,746 | SH | SOLE | 295,746 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 2,256 | 185,666 | SH | SOLE | 185,666 | 0 | 0 | ||
FORMA THERAPEUTICS HLDGS INC | SHS | 34633R104 | 1,625 | 174,768 | SH | SOLE | 174,768 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 2,543 | 41,002 | SH | SOLE | 41,002 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 7,096 | 67,442 | SH | SOLE | 67,442 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 3,558 | 445,334 | SH | SOLE | 445,334 | 0 | 0 | ||
IMMUNIC INC | COM | 4525EP101 | 774 | 68,475 | SH | SOLE | 68,475 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 1,428 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
IMMUNOGEN INC | COM | 45253H101 | 3,070 | 645,000 | SH | SOLE | 645,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 2,399 | 102,067 | SH | SOLE | 102,067 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 18,897 | 308,819 | SH | SOLE | 308,819 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 4,468 | 138,843 | SH | SOLE | 138,843 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 1,592 | 94,600 | SH | Put | SOLE | 94,600 | 0 | 0 | |
JOUNCE THERAPEUTICS INC | COM | 481116101 | 1,686 | 248,347 | SH | SOLE | 248,347 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 3,093 | 46,489 | SH | SOLE | 46,489 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM | 52187K101 | 1,806 | 1,032,163 | SH | SOLE | 1,032,163 | 0 | 0 | ||
LUCIRA HEALTH INC | COM | 54948U105 | 1,109 | 310,734 | SH | SOLE | 310,734 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 1,283 | 131,151 | SH | SOLE | 131,151 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 21 | 49,990 | SH | SOLE | 49,990 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 264 | 235,515 | SH | SOLE | 235,515 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 8,586 | 324,719 | SH | SOLE | 324,719 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 3,792 | 46,122 | SH | SOLE | 46,122 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 2,759 | 68,709 | SH | SOLE | 68,709 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 1,920 | 20,482 | SH | SOLE | 20,482 | 0 | 0 | ||
NEXTCURE INC | COM | 65343E108 | 953 | 196,187 | SH | SOLE | 196,187 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 3,058 | 200,494 | SH | SOLE | 200,494 | 0 | 0 | ||
OTONOMY INC | COM | 68906L105 | 2,898 | 1,207,385 | SH | SOLE | 1,207,385 | 0 | 0 | ||
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 1,631 | 204,679 | SH | SOLE | 204,679 | 0 | 0 | ||
POLYPID LTD | SHS | M8001Q118 | 1,191 | 218,175 | SH | SOLE | 218,175 | 0 | 0 | ||
POSEIDA THERAPEUTICS INC | COM | 73730P108 | 1,074 | 239,696 | SH | SOLE | 239,696 | 0 | 0 | ||
RENOVACOR INC | *W EXP 99/99/999 | 75989E114 | 33 | 104,828 | SH | SOLE | 104,828 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 1,578 | 10,956 | SH | SOLE | 10,956 | 0 | 0 | ||
SERES THERAPEUTICS INC | COM | 81750R102 | 2,327 | 326,872 | SH | SOLE | 326,872 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 14,210 | 443,381 | SH | SOLE | 443,381 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 26,964 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
STEREOTAXIS INC | COM NEW | 85916J409 | 1,292 | 346,405 | SH | SOLE | 346,405 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 1,763 | 101,447 | SH | SOLE | 101,447 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 2,662 | 14,836 | SH | SOLE | 14,836 | 0 | 0 | ||
VERACYTE INC | COM | 92337F107 | 11,733 | 425,554 | SH | SOLE | 425,554 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 1,993 | 7,638 | SH | SOLE | 7,638 | 0 | 0 | ||
VIEWRAY INC | COM | 92672L107 | 1,709 | 436,096 | SH | SOLE | 436,096 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 2,332 | 126,136 | SH | SOLE | 126,136 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,428 | 101,081 | SH | SOLE | 101,081 | 0 | 0 |